Novo Nordisk A/S
(NYSE : NVO)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Do You Like Swing Trading?
Learn how we win with easy 3-5 day holds.
Be 'active' in the market while NOT being tied to your desk.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Major
symbolcompany%chnglast%shortavg$volume
JNJJohnson & Johnson
0.27%130.780.7%$942.40m
PFEPfizer Inc.
-1.02%36.900.9%$755.01m
MRKMerck & Co., Inc.
-0.16%82.630.7%$614.29m
ABBVAbbVie, Inc.
-0.45%70.512.3%$551.14m
BMYBristol-Myers Squibb Company
-0.40%49.411.4%$446.07m
LLYEli Lilly and Company
-0.54%110.871.0%$340.63m
AZNAstraZeneca PLC Sponsored ADR
-0.33%42.761.2%$134.10m
NVSNovartis AG Sponsored ADR
-2.81%86.980.2%$129.52m
GSKGlaxoSmithKline plc Sponsored ADR
-0.37%40.880.3%$82.40m
NVONovo Nordisk A/S Sponsored ADR Class B
-0.32%49.510.1%$68.02m
SNYSanofi Sponsored ADR
-0.21%43.710.2%$51.16m
LCILannett Company, Inc.
0.29%13.9335.6%$50.62m
AKTXAkari Therapeutics Plc Sponsored ADR
-2.05%1.911.6%$2.42m
EPIXESSA Pharma Inc
-1.96%3.000.1%$0.18m

Company Profile

Novo Nordisk A/S is a healthcare company, which engages in the research, development, manufacture, and marketing of pharmaceutical products. It operates through the following segments: Diabetes & Obesity Care, and Biopharmaceuticals. The Diabetes & Obesity Care segment covers products for insulin; GLP-1 and related delivery systems; oral antidiabetic products; and obesity. The Biopharmaceuticals segment offers products for haemophilia; growth hormone therapy; and hormone replacement therapy. The company was founded by Harald Pedersen and Thorvald Pedersen in 1925 is headquartered in Bagsværd, Denmark.